Search

Your search keyword '"Kazi Rubiya Fatema"' showing total 3 results
Start Over Author "Kazi Rubiya Fatema"
3 results on '"Kazi Rubiya Fatema"'

1. A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh

Author

Arifa Sultana, Saimon Shahriar, Md. Rafat Tahsin, Sabiha Rahman Mim, Kazi Rubiya Fatema, Ananya Saha, Fahmida Yesmin, Nasiba Binte Bahar, Mithun Samodder, Md. Ariful Haque Mamun, Md. Aknur Rahman, Sonia Ferdousy, Tahmina Akter, Fahima Aktar, Md. Ruhul Kuddus, Md. Mustafizur Rahman, Md. Moklesur Rahman Sarker, Sultan Mehtap Büyüker, Jakir Ahmed Chowdhury, Abu Asad Chowdhury, Shaila Kabir, Md. Akter Hossain, and Md. Shah Amran

Subjects
pharmacovigilance, side-effects, SARS-CoV-2, adverse events following immunization, vaccines, cross-sectional study, Medicine
Abstract

Background: The Oxford–AstraZeneca vaccine (Covishield) was the first to be introduced in Bangladesh to fight the ongoing global COVID-19 pandemic. As this vaccine had shown some side-effects in its clinical trial, we aimed to conduct a study assessing short-term adverse events following immunization (AEFIs) in Bangladesh. Method: A cross-sectional study was conducted on social and electronic media platforms by delivering an online questionnaire among people who had taken at least one dose of the COVID-19 vaccine. The collected data were then analysed to evaluate various parameters related to the AEFIs of the respondents. Results: A total of 626 responses were collected. Of these, 623 were selected based on complete answers and used for the analysis. Most of the respondents were between 30–60 years of age, and 40.4% were female. We found that a total of 8.5% of the total respondents had been infected with the SARS-CoV-2 virus. Our survey revealed that out of 623 volunteers, 317 reported various side-effects after taking the vaccine, which is about 50.88% of the total participants. The majority of participants (37.07%, 231/623) reported swelling and pain at the injection site and fever (25.84%, 162/623); these were some of the common localized and generalized symptoms after the COVID-19 vaccine administration. Conclusion: The side-effects reported after receiving the Oxford–AstraZeneca vaccine (Covishield) are similar to those reported in clinical trials, demonstrating that the vaccines have a safe therapeutic window. Moreover, further research is needed to determine the efficacy of existing vaccines in preventing SARS-CoV-2 infections or after-infection hospitalization.

Published
2021
Full Text
View/download PDF

2. Assessing the Self-reported After Events Following Immunization of COVID-19 Vaccines in Turkey and Bangladesh

Author

Arifa Sultana, Sabiha Rahman Mim, Ananya Saha, Fahmida Yesmin, Md. Rafat Tahsin, Nasiba Binte Bahar, Kazi Rubiya Fatema, Saimon Shahriar, Kazi Milenur Rahman Prattay, Fazle Rabbi, Fabiha Noushin, Mithun Samodder, Qurratul Ain Sadia, Jannatul Ferdous, Md. Ariful Haque Mamun, Mohammad Ikram Uddin, Tahmina Akter, Md. Mustafizur Rahman, Md. Moklesur Rahman Sarker, Md. Ruhul Kuddus, Fahima Aktar, Jakir Ahmed Chowdhury, Abu Asad Chowdhury, Shaila Kabir, Sultan Mehtap Büyüker, Md. Sohanur Rahman, Md. Habibur Rahman, and Md. Shah Amran

Subjects
Health, Toxicology and Mutagenesis, Environmental Chemistry, General Medicine, Pollution
Published
2023

3. A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh

Author

Sonia Ferdousy, Jakir Ahmed Chowdhury, Abu Asad Chowdhury, Aknur Rahman, Ariful Haque Mamun, Sabiha Rahman Mim, Akter Hossain, Nasiba Binte Bahar, Mustafizur Rahman, Md. Moklesur Rahman Sarker, Tahmina Akter, Ruhul Kuddus, Ananya Saha, Rafat Tahsin, Shaila Kabir, Kazi Rubiya Fatema, Saimon Shahriar, Mithun Samodder, Sultan Mehtap Büyüker, Shah Amran, Fahima Aktar, Arifa Sultana, and Fahmida Yesmin

Subjects
medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Cross-sectional study, Immunology, Computer-assisted web interviewing, adverse events following immunization, Article, Internal medicine, Drug Discovery, Pandemic, Pharmacovigilance, medicine, cross-sectional study, Pharmacology (medical), Adverse effect, Pharmacology, business.industry, SARS-CoV-2, Public Health, Global Health, Social Medicine and Epidemiology, vaccines, Clinical trial, Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi, Infectious Diseases, Immunization, pharmacovigilance, side-effects, Medicine, business
Abstract

Background: The Oxford–AstraZeneca vaccine (Covishield) was the first to be introduced in Bangladesh to fight the ongoing global COVID-19 pandemic. As this vaccine had shown some side-effects in its clinical trial, we aimed to conduct a study assessing short-term adverse events following immunization (AEFIs) in Bangladesh. Method: A cross-sectional study was conducted on social and electronic media platforms by delivering an online questionnaire among people who had taken at least one dose of the COVID-19 vaccine. The collected data were then analysed to evaluate various parameters related to the AEFIs of the respondents. Results: A total of 626 responses were collected. Of these, 623 were selected based on complete answers and used for the analysis. Most of the respondents were between 30–60 years of age, and 40.4% were female. We found that a total of 8.5% of the total respondents had been infected with the SARS-CoV-2 virus. Our survey revealed that out of 623 volunteers, 317 reported various side-effects after taking the vaccine, which is about 50.88% of the total participants. The majority of participants (37.07%, 231/623) reported swelling and pain at the injection site and fever (25.84%, 162/623), these were some of the common localized and generalized symptoms after the COVID-19 vaccine administration. Conclusion: The side-effects reported after receiving the Oxford–AstraZeneca vaccine (Covishield) are similar to those reported in clinical trials, demonstrating that the vaccines have a safe therapeutic window. Moreover, further research is needed to determine the efficacy of existing vaccines in preventing SARS-CoV-2 infections or after-infection hospitalization.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results